Karen Jean Ferrante - 19 May 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol
MGNX
Transactions as of
19 May 2022
Net transactions value
$0
Form type
4
Filing time
23 May 2022, 21:06:25 UTC
Previous filing
05 Apr 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Stock Option (right to buy) Award $0 +18,000 $0.000000 18,000 19 May 2022 Common Stock 18,000 $3.90 Direct F1
transaction MGNX Stock Option (right to buy) Award $0 +20,640 $0.000000 20,640 19 May 2022 Common Stock 20,640 $3.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F2 At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.